The association of the HOPA12bp polymorphism with schizophrenia in the NIMH Genetics Initiative for Schizophrenia sample

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 144, Issue 6, 2007, Pages 743-747

  Philibert, Robert A ^a,b   Bohle, Phil ^a   Secrest, Dianna ^a   Deaderick, Jessica ^a   Sandhu, Harinder ^a   Crowe, Raymond ^a   Black, Donald W ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

HOPA; MED12; Mediator; Schizophrenia

Indexed keywords

ALLELISM; ARTICLE; FEMALE; GENE INSERTION; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MALE; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; X CHROMOSOME;

ALLELES; BASE SEQUENCE; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENES, X-LINKED; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PEDIGREE; POLYMORPHISM, GENETIC; RECEPTORS, THYROID HORMONE; RISK FACTORS; SCHIZOPHRENIA;

EID: 34548700129     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30489     Document Type: Article

References (25)

1. Belakavadi M, Fondell JD. 2006. Role of the mediator complex in nuclear hormone receptor signaling. Rev Physiol Biochem Pharmacol 156:23-43.
2. Beyer KS, Klauck SM, Benner A, Poustka F, Poustka A. 2002. Association studies of the HOPA dodecamer duplication variant in different subtypes of autism. Am J Med Genet 114(1):110-115.
3. Dean M, Carrington M, O'Brien SJ. 2002. Balanced polymorphism selected by genetic versus infectious human disease. Annu Rev Genomics Hum Genet 3:263-292.
4. DeLisi LE, Smith AB, Razi K, Stewart J, Wang Z, Sandhu HK, Philibert RA. 2000. Investigation of a candidate gene for schizophrenia on Xq13 previously associated with mental retardation and hypothyroidism. Am J Med Genet 96(3):398-403.
5. Friez MJ, Essop FB, Krause A, Castiglia L, Ragusa A, Sossey-Alaoui K, Nelson RL, May MM, Michaelis RC, Srivastava AK, et al. 2000. Evidence that a dodecamer duplication in the gene HOPA in Xq13 is not associated with mental retardation. Hum Genet 106(1):36-39.
6. Hong S-K, Haldin CE, Lawson ND, Weinstein BM, Dawid IB, Hukriede NA. 2005. The zebrafish kohtalo/trap230 gene is required for the development of the brain, neural crest, and pronephric kidney. PNAS 102(51):18473-18478.
7. Ito M, Yuan CX, Malik S, Gu W, Fondell JD, Yamamura S, Fu ZY, Zhang X, Qin J, Roeder RG. 1999. Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol Cell 3(3):361-370.
8. 12bp polymorphism in schizophrenia and manic depressive illness. Am J Med Genet Part B 118B(1):16-19.
9. Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM. 1982. Best estimate of lifetime psychiatric diagnosis: A methodological study. Arch Gen Psychiatry 39(8):879-883.
10. Moghal N, Sternberg PW. 2003. A component of the transcriptional mediator complex inhibits RAS-dependent vulval fate specification in C. elegans. Development 130(1):57-69.
11. Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T. 1994. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 51(11):849-859; discussion 863-864.
12. 12bp polymorphism and schizophrenia. Psychiatr Genet 16(2):73-76.
13. Philibert RA, King BH, Winfield S, Cook EH, Lee YH, Stubblefield B, Damschroder-Williams P, Dea C, Palotie A, Tengstrom C, et al. 1998. Association of an X-chromosome dodecamer insertional variant allele with mental retardation. [erratum appears in Mol Psychiatry 1999 Mar;4(2):197.]. Molecular Psychiatry 3(4):303-309.
14. Philibert RA, Winfield SL, Damschroder-Williams P, Tengstrom C, Martin BM, Ginns EI. 1999. The genomic structure and developmental expression patterns of the human OPA-containing gene (HOPA). Hum Genet 105(1-2):174-178.
15. 12bp polymorphism for schizophrenia and hypothyroidism. Am J Med Genet 105(1):130-134.
16. Pietsch J, Delalande J-M, Jakaitis B, Stensby JD, Dohle S, Talbot WS, Raible DW, Shepherd IT. 2006. Lessen encodes a zebrafish trap100 required for enteric nervous system development. Development 133(3):395-406.
17. Rachez C, Freedman LP. 2001. Mediator complexes and transcription. Curr Opin Cell Biol 13(3):274-280.
18. Rau MJ, Fischer S, Neumann CJ. 2006. Zebrafish Trap230/Med12 is required as a coactivator for Sox9-dependent neural crest, cartilage and ear development. Dev Biol 296(1):83-93.
19. Sandhu HK, Sarkar M, Turner BM, Wassink TH, Philibert RA. 2003. Polymorphism analysis of HOPA: A candidate gene for schizophrenia. Am J Med Genet Part B 123B(1):33-38.
20. 12bp allele with a large X-chromosome haplotype and positive symptom schizophrenia. Am J Med Genet Part B 127B(1):20-27.
21. Suarez BK, Duan J, Sanders AR, Hinrichs AL, Jin CH, Hou C, Buccola NG, Hale N, Weilbaecher AN, Nertney DA, et al. 2006. Genomewide linkage scan of 409 European-Ancestry and African American families with schizophrenia: Suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. Am J Hum Genet 78(2):315-333.
22. Uitenbroek DG. 1997. SISA binomial. Southampton: D.G. Uitenbroek. Retrieved January 01, 2004, http://home.clara.net/sisa/binomial.htm.
23. Wassertheil-Smoller S, Shumaker S, Ockene J, Talavera GA, Greenland P, Cochrane B, Robbins J, Aragaki A, Dunbar-Jacob J. 2004. Depression and cardiovascular sequelae in postmenopausal women: The women's health initiative (WHI). Arch Intern Med 164(3):289-298.
24. Zhang H, Emmons SW. 2000. A C. elegans mediator protein confers regulatory selectivity on lineage-specific expression of a transcription factor gene. Genes Dev 14(17):2161-2172.
25. Zhou R, Bonneaud N, Yuan CX, de Santa Barbara P, Boizet B, Tibor S, Scherer G, Roeder RG, Poulat F, Berta P. 2002. SOX9 interacts with a component of the human thyroid hormone receptor-associated protein complex. Nucleic Acids Res 30(14):3245-3252.